Claudia Sorbi

Prof. Claudia Sorbi

Life Sciences, University of Modena and Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2003 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LBLivio Brasili
Livio Brasili
Claudia SorbiClaudia Sorbi
Claudia Sorbi
SFSilvia Franchini
Silvia Franchini
MMMassimo Manicardi
Massimo Manicardi
PAPiero Angeli
Piero Angeli
EPElena Poggesi
Elena Poggesi

11 March 2009 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
Claudia SorbiClaudia Sorbi
Claudia Sorbi
SFSilvia Franchini
Silvia Franchini
ATAnnalisa Tait
Annalisa Tait
APAdolfo Prandi
Adolfo Prandi
RGRossella Gallesi
Rossella Gallesi
LBLivio Brasili
Livio Brasili

4 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
LPLuca Pinzi
Luca Pinzi
NBNicolo Bisi
Nicolo Bisi
Claudia SorbiClaudia Sorbi
Claudia Sorbi
SFSilvia Franchini
Silvia Franchini
Nicolo TonaliNicolo Tonali
Nicolo Tonali
Giulio RastelliGiulio Rastelli
Giulio Rastelli
Tau is a protein characterized by large structural portions displaying extended conformational changes. Unfortunately, the accumulation of this protein into toxic aggregates in neuronal cells leads to a number of severe pathologies, collectively named tauopathies. In the last decade, significant research advancements were achieved, including a better understanding of Tau structures and their implication in different tauopathies. Interestingly, Tau is characterized by a high structural variability depending on the type of disease, the crystallization conditions, and the formation of pathologic aggregates obtained from in vitro versus ex vivo samples. In this review, we reported an up-to-date and comprehensive overview of Tau structures reported in the Protein Data Bank, with a special focus on discussing the connections between structural features, different tauopathies, different crystallization conditions, and the use of in vitro or ex vivo samples. The information reported in this article highlights very interesting links between all these aspects, which we believe may be of particular relevance for a more informed structure-based design of compounds able to modulate Tau aggregation.

1 September 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SFSilvia Franchini
Silvia Franchini
APAdolfo Prandi
Adolfo Prandi
ABAnnamaria Baraldi
Annamaria Baraldi
Claudia SorbiClaudia Sorbi
Claudia Sorbi
ATAnnalisa Tait
Annalisa Tait
Paola FossaPaola Fossa
Paola Fossa

1 March 2010 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
SFSilvia Franchini
Silvia Franchini
APAdolfo Prandi
Adolfo Prandi
Claudia SorbiClaudia Sorbi
Claudia Sorbi
ATAnnalisa Tait
Annalisa Tait
ABAnnamaria Baraldi
Annamaria Baraldi
LBLivio Brasili
Livio Brasili

1 January 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
PLPasquale Linciano
Pasquale Linciano
RBRosaria Benedetti
Rosaria Benedetti
LPLuca Pinzi
Luca Pinzi
FRFabiana Russo
Fabiana Russo
UCUgo Chianese
Ugo Chianese
SFSilvia Franchini
Silvia Franchini